(CGEM) Cullinan Oncology - Performance -72.3% in 12m
Compare CGEM with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-72.65%
#105 in Group
Rel. Strength
5.93%
#7485 in Universe
Total Return 12m
-72.25%
#140 in Group
Total Return 5y
-74.79%
#76 in Group
P/E -
(?) Percentile in Group
P/E Forward 6.30
34th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
21th Percentile in Group
12m Total Return: CGEM (-72.3%) vs XBI (-14%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: CGEM vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CGEM
Total Return (including Dividends) | CGEM | XBI | S&P 500 |
---|---|---|---|
1 Month | -3.21% | 2.02% | 2.87% |
3 Months | -25.35% | -15.44% | -6.42% |
12 Months | -72.25% | -14.02% | 9.87% |
5 Years | -74.79% | -26.47% | 107.51% |
Trend Score (consistency of price movement) | CGEM | XBI | S&P 500 |
1 Month | 18.1% | 57% | 89.4% |
3 Months | -68.9% | -82.3% | -72% |
12 Months | -95.3% | -53.1% | 49.3% |
5 Years | -51.0% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #70 | -5.12% | -5.91% |
3 Month | #84 | -11.7% | -20.2% |
12 Month | #140 | -67.7% | -74.7% |
5 Years | #64 | -50.8% | -84.0% |
FAQs
Does CGEM Cullinan Oncology outperforms the market?
No,
over the last 12 months CGEM made -72.25%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months CGEM made -25.35%, while XBI made -15.44%.
Over the last 3 months CGEM made -25.35%, while XBI made -15.44%.
Performance Comparison CGEM vs Indeces and Sectors
CGEM vs. Indices CGEM is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -13.8% | -6.08% | -51.2% | -82.1% |
US NASDAQ 100 | QQQ | -14.0% | -7.92% | -51.6% | -83.6% |
US Dow Jones Industrial 30 | DIA | -14.1% | -4.82% | -50.2% | -78.6% |
German DAX 40 | DAX | -15.9% | -22.5% | -76.8% | -97.3% |
Shanghai Shenzhen CSI 300 | CSI 300 | -14.5% | -9.48% | -50.4% | -77.9% |
Hongkong Hang Seng | HSI | -17.3% | -19.4% | -60.7% | -84.3% |
India NIFTY 50 | INDA | -11.4% | -5.49% | -53.1% | -74.6% |
Brasil Bovespa | EWZ | -15.8% | -14.7% | -60.4% | -65.8% |
CGEM vs. Sectors CGEM is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -14.0% | -6.88% | -57.4% | -92.6% |
Consumer Discretionary | XLY | -14.7% | -6.72% | -49.0% | -86.3% |
Consumer Staples | XLP | -13.4% | -5.23% | -58.1% | -79.8% |
Energy | XLE | -14.8% | -3.29% | -45.2% | -62.5% |
Financial | XLF | -14.4% | -8.78% | -57.1% | -93.8% |
Health Care | XLV | -10.0% | 1.17% | -46.0% | -66.3% |
Industrial | XLI | -15.4% | -10.6% | -52.2% | -82.2% |
Materials | XLB | -13.8% | -7.92% | -47.1% | -66.2% |
Real Estate | XLRE | -13.5% | -9.33% | -53.6% | -85.7% |
Technology | XLK | -14.7% | -9.95% | -48.9% | -79.3% |
Utilities | XLU | -14.8% | -8.83% | -59.0% | -88.2% |
Aerospace & Defense | XAR | -14.3% | -12.6% | -60.5% | -97.4% |
Biotech | XBI | -5.71% | -5.23% | -30.1% | -58.2% |
Homebuilder | XHB | -13.4% | -6.28% | -37.6% | -62.5% |
Retail | XRT | -13.9% | -6.80% | -44.9% | -67.9% |